1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow ER 30346: new trials by email Literature Review of ER 30346 trials Research Report on ER 30346
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation ravuconazole - Breast Cancer, Chronic Myeloproliferative Disorders | Phase 1 / Phase 2 | Completed | National Institutes of Health Clinical Center (CC) | 2003-06-01 | 2012-03-08 |
Blast Crisis (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Ovarian Epithelial (1) · Congenital Abnormalities (1) · Gestational Trophoblastic Disease (1) · Hodgkin Disease (1) · Infections (1) · Leukemia (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myeloid, Chronic-Phase (1)
National Institutes of Health Clinical Center (CC) (1)
United States (1)